<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37670171</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-4726</ISSN><JournalIssue CitedMedium="Internet"><Volume>280</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery</Title><ISOAbbreviation>Eur Arch Otorhinolaryngol</ISOAbbreviation></Journal><ArticleTitle>Distinct smell and taste disorder phenotype of post-acute COVID-19 sequelae.</ArticleTitle><Pagination><StartPage>5115</StartPage><EndPage>5128</EndPage><MedlinePgn>5115-5128</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00405-023-08163-x</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Olfactory dysfunction (OD) commonly accompanies coronavirus disease 2019 (COVID-19). We investigated the kinetics of OD resolution following SARS-CoV-2 infection (wild-type and alpha variant) and its impact on quality of life, physical and mental health.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">OD prevalence was assessed in an ambulatory COVID-19 survey (n&#x2009;=&#x2009;906,&#x2009;&#x2265;&#x2009;90&#xa0;days follow-up) and an observational cohort of ambulatory and hospitalized individuals (n&#x2009;=&#x2009;108, 360&#xa0;days follow-up). Co-occurrence of OD with other symptoms and effects on quality of life, physical and mental health were analyzed by multi-dimensional scaling, association rule mining and semi-supervised clustering.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Both in the ambulatory COVID-19 survey study (72%) and the observational ambulatory and hospitalized cohort (41%) self-reported OD was frequent during acute COVID-19. Recovery from self-reported OD was slow (survey: median 28&#xa0;days, observational cohort: 90&#xa0;days). By clustering of the survey data, we identified a predominantly young, female, comorbidity-free group of convalescents with persistent OD and taste disorders (median recovery: 90&#xa0;days) but low frequency of post-acute fatigue, respiratory or neurocognitive symptoms. This smell and taste disorder cluster was characterized by a high rating of physical performance, mental health, and quality of life as compared with convalescents affected by prolonged fatigue or neurocognitive complaints.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results underline the heterogeneity of post-acute COVID-19 sequelae calling for tailored management strategies. The persistent smell and taste disorder phenotype is characterized by good clinical, physical, and mental recovery and may pose a minor challenge for public health.</AbstractText><AbstractText Label="STUDY REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov: NCT04661462 (survey study), NCT04416100 (observational cohort).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rass</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tymoszuk</LastName><ForeName>Piotr</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Data Analytics as a Service Tirol, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahanic</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heim</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ausserhofer</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of General Practice and Public Health, Claudiana College of Health Professions, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindner</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kofler</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahlknecht</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boehm</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;fner</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pizzini</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnweber</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Innsbruck, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division for Health Networking and Telehealth, Biomedical Informatics and Mechatronics, UMIT, Hall in Tyrol, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiechl</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peball</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kindl</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putnina</LastName><ForeName>Lauma</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fava</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djamshidian</LastName><ForeName>Atbin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huber</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Tyrolean Federal Institute for Integrated Care, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiedermann</LastName><ForeName>Christian J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Institute of General Practice and Public Health, Claudiana College of Health Professions, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sperner-Unterweger</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>W&#xf6;ll</LastName><ForeName>Ewald</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, St. Vinzenz Hospital, Zams, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beer</LastName><ForeName>Ronny</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schiefecker</LastName><ForeName>Alois Josef</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellmann-Weiler</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachler</LastName><ForeName>Herbert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of General Medicine, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tancevski</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pfausler</LastName><ForeName>Bettina</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piccoliori</LastName><ForeName>Giuliano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of General Practice and Public Health, Claudiana College of Health Professions, Bolzano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seppi</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf6;ffler-Ragg</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria. judith.loeffler@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helbok</LastName><ForeName>Raimund</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5682-0145</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. raimund.helbok@i-med.ac.at.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Johannes Kepler University, Linz, Austria. raimund.helbok@i-med.ac.at.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04661462</AccessionNumber><AccessionNumber>NCT04416100</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>GZ 71934</GrantID><Agency>Land Tirol</Agency><Country/></Grant><Grant><GrantID>IIS 1199-0424</GrantID><Agency>Boehringer Ingelheim</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Otorhinolaryngol</MedlineTA><NlmUniqueID>9002937</NlmUniqueID><ISSNLinking>0937-4477</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012903" MajorTopicYN="N">Smell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013649" MajorTopicYN="N">Taste</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013651" MajorTopicYN="N">Taste Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Olfactory dysfunction</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Smell and taste disorder</Keyword></KeywordList><CoiStatement>No support from any organization for the submitted work; PT owns a data science enterprise, Data Analytics as a Service Tirol, and has received an honorarium for statistical data analysis and scientific writing of the manuscript; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>6</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>23</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37670171</ArticleId><ArticleId IdType="pmc">PMC10562286</ArticleId><ArticleId IdType="doi">10.1007/s00405-023-08163-x</ArticleId><ArticleId IdType="pii">10.1007/s00405-023-08163-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sahanic S, Tymoszuk P, Ausserhofer D, et al. Phenotyping of acute and persistent coronavirus disease 2019 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey. Clin Infect Dis. 2022;75:e418&#x2013;e431. doi: 10.1093/cid/ciab978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab978</ArticleId><ArticleId IdType="pmc">PMC8767855</ArticleId><ArticleId IdType="pubmed">34849652</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021 doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Ausserhofer D, et al. Who Is at risk of poor mental health following coronavirus disease-19 outpatient management? Front Med. 2022 doi: 10.3389/fmed.2022.792881.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.792881</ArticleId><ArticleId IdType="pmc">PMC8964263</ArticleId><ArticleId IdType="pubmed">35360744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021 doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Tymoszuk P, Sahanic S, et al. Investigating phenotypes of pulmonary COVID-19 recovery: a longitudinal observational prospective multicenter trial. Elife. 2022 doi: 10.7554/ELIFE.72500.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.72500</ArticleId><ArticleId IdType="pmc">PMC8896831</ArticleId><ArticleId IdType="pubmed">35131031</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9/ATTACHMENT/31179DEC-CF64-455B-BD13-6EF0045B7DD6/MMC1.PDF.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9/ATTACHMENT/31179DEC-CF64-455B-BD13-6EF0045B7DD6/MMC1.PDF</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R, Bili&#x144;ska K, von Bartheld C. Why does the omicron variant largely spare olfactory function? Implications for the pathogenesis of anosmia in coronavirus disease 2019. J Infect Dis. 2022 doi: 10.1093/INFDIS/JIAC113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAC113</ArticleId><ArticleId IdType="pmc">PMC9129133</ArticleId><ArticleId IdType="pubmed">35467743</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, French E, Costanzo RM. Decreasing incidence of chemosensory changes by COVID-19 variant. Otolaryngol Head Neck Surg. 2022 doi: 10.1177/01945998221097656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01945998221097656</ArticleId><ArticleId IdType="pmc">PMC9630171</ArticleId><ArticleId IdType="pubmed">35503739</ArticleId></ArticleIdList></Reference><Reference><Citation>Saniasiaya J, Islam MA, Abdullah B. Prevalence of olfactory dysfunction in coronavirus disease 2019 (COVID-19): a meta-analysis of 27,492 patients. Laryngoscope. 2021;131:865&#x2013;878. doi: 10.1002/LARY.29286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/LARY.29286</ArticleId><ArticleId IdType="pmc">PMC7753439</ArticleId><ArticleId IdType="pubmed">33219539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjanaumporn J, Aeumjaturapat S, Snidvongs K, et al. Smell and taste dysfunction in patients with SARS-CoV-2 infection: a review of epidemiology, pathogenesis, prognosis, and treatment options. Asian Pacific J allergy Immunol. 2020;38:69&#x2013;77. doi: 10.12932/AP-030520-0826.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-030520-0826</ArticleId><ArticleId IdType="pubmed">32563234</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazhytska M, Kodra A, Hoagland DA, et al. Non-cell-autonomous disruption of nuclear architecture as a potential cause of COVID-19-induced anosmia. Cell. 2022;185:1052&#x2013;1064.e12. doi: 10.1016/J.CELL.2022.01.024/ATTACHMENT/A078E479-C54C-418F-9475-F789CFE2E8C3/MMC2.XLSX.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.01.024/ATTACHMENT/A078E479-C54C-418F-9475-F789CFE2E8C3/MMC2.XLSX</ArticleId><ArticleId IdType="pmc">PMC8808699</ArticleId><ArticleId IdType="pubmed">35180380</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat AR, Gengler I, Speth MM. Olfactory dysfunction: a highly prevalent symptom of COVID-19 with public health significance. Otolaryngol Head Neck Surg. 2020;163:12&#x2013;15. doi: 10.1177/0194599820926464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820926464</ArticleId><ArticleId IdType="pubmed">32366160</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503. doi: 10.1136/BMJ-2021-069503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2021-069503</ArticleId><ArticleId IdType="pmc">PMC9326326</ArticleId><ArticleId IdType="pubmed">35896188</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Fabbris C, Polesel J, et al. Two-year prevalence and recovery rate of altered sense of smell or taste in patients with mildly symptomatic COVID-19. JAMA Otolaryngol Neck Surg. 2022 doi: 10.1001/JAMAOTO.2022.1983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAOTO.2022.1983</ArticleId><ArticleId IdType="pmc">PMC9353700</ArticleId><ArticleId IdType="pubmed">35925596</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipirdamaz C, Zayet S, Osman M, et al. Asthma and cacosmia could be predictive factors of olfactory dysfunction persistence 9 months after SARS-CoV-2 infection: the ANOSVID study. Life. 2022 doi: 10.3390/LIFE12070929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/LIFE12070929</ArticleId><ArticleId IdType="pmc">PMC9319724</ArticleId><ArticleId IdType="pubmed">35888019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Chiesa-Estomba CM, Beckers E, et al. Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients. J Intern Med. 2021;290:451&#x2013;461. doi: 10.1111/JOIM.13209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JOIM.13209</ArticleId><ArticleId IdType="pubmed">33403772</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Riestra-Ayora J, Yanes-Diaz J, Esteban-Sanchez J, et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Otorhinolaryngol. 2021;278:4831&#x2013;4837. doi: 10.1007/S00405-021-06764-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-021-06764-Y</ArticleId><ArticleId IdType="pmc">PMC8004560</ArticleId><ArticleId IdType="pubmed">33774737</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira LA, Gessa C, Deiana G, et al. The effects of persistent olfactory and gustatory dysfunctions on quality of life in long-COVID-19 patients. Life (Basel, Switzerland) 2022 doi: 10.3390/LIFE12020141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/LIFE12020141</ArticleId><ArticleId IdType="pmc">PMC8878431</ArticleId><ArticleId IdType="pubmed">35207429</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Guida F, Polesel J, et al. Self-reported smell and taste recovery in coronavirus disease 2019 patients: a one-year prospective study. Eur Arch Oto-Rhino-Laryngology. 2022;279:515. doi: 10.1007/S00405-021-06839-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-021-06839-W</ArticleId><ArticleId IdType="pmc">PMC8103884</ArticleId><ArticleId IdType="pubmed">33963433</ArticleId></ArticleIdList></Reference><Reference><Citation>Prem B, Liu DT, Besser G, et al. Long-lasting olfactory dysfunction in COVID-19 patients. Eur Arch Otorhinolaryngol. 2021 doi: 10.1007/S00405-021-07153-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-021-07153-1</ArticleId><ArticleId IdType="pmc">PMC8578909</ArticleId><ArticleId IdType="pubmed">34757458</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho DH, Reiter ER, Budd SG, et al. Quality of life and safety impact of COVID-19 associated smell and taste disturbances. Am J Otolaryngol. 2021;42:103001. doi: 10.1016/J.AMJOTO.2021.103001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AMJOTO.2021.103001</ArticleId><ArticleId IdType="pmc">PMC7983361</ArticleId><ArticleId IdType="pubmed">33773440</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudine L, Canaletti C, Giudici F, et al. Investigation on the Loss of taste and smell and consequent psychological effects: a cross-sectional study on healthcare workers who contracted the COVID-19 infection. Front Public Heal. 2021;9:511. doi: 10.3389/FPUBH.2021.666442/BIBTEX.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPUBH.2021.666442/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8193118</ArticleId><ArticleId IdType="pubmed">34123991</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabady S, Altenberger J, Brose M, et al. Guideline S1: long COVID: diagnostics and treatment strategies. Wien Klin Wochenschr. 2021;133:237&#x2013;278. doi: 10.1007/S00508-021-01974-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00508-021-01974-0</ArticleId><ArticleId IdType="pmc">PMC8633909</ArticleId><ArticleId IdType="pubmed">34851455</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldundag A, Yilmaz E, Kesimli MC. Modified olfactory training is an effective treatment method for COVID-19 induced parosmia. Laryngoscope. 2022 doi: 10.1002/LARY.30101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/LARY.30101</ArticleId><ArticleId IdType="pmc">PMC9088368</ArticleId><ArticleId IdType="pubmed">35257391</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien JR, Vaira LA, Saussez S. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicenter prospective study. J Intern Med. 2022 doi: 10.1111/JOIM.13564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/JOIM.13564</ArticleId><ArticleId IdType="pmc">PMC9538281</ArticleId><ArticleId IdType="pubmed">36000469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahanic S, Tymoszuk P, Luger AK, et al. COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial. ERJ open Res. 2023;9:00317&#x2013;02022. doi: 10.1183/23120541.00317-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00317-2022</ArticleId><ArticleId IdType="pmc">PMC10030059</ArticleId><ArticleId IdType="pubmed">36960350</ArticleId></ArticleIdList></Reference><Reference><Citation>Austrian Agency for Health and Food Safety (AGES) SARS-CoV-2-Varianten in &#xd6;sterreich. https://www.ages.at/en/topics/pathogenic-organism/coronavirus/sars-cov-2-varianten-in-oesterreich/. Accessed 5 Aug 2021</Citation></Reference><Reference><Citation>L&#xf6;we B, Wahl I, Rose M, et al. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population. J Affect Disord. 2010;122:86&#x2013;95. doi: 10.1016/j.jad.2009.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2009.06.019</ArticleId><ArticleId IdType="pubmed">19616305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xe4;fe K, Zipfel S, Herzog W, L&#xf6;we B. Screening psychischer st&#xf6;rungen mit dem &#x201c;Gesundheitsfragebogen f&#xfc;r Patienten (PHQ-D)&#x201d;. Ergebnisse der Deutschen validierungsstudie Diagnostica. 2004;50:171&#x2013;181. doi: 10.1026/0012-1924.50.4.171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1026/0012-1924.50.4.171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Kobal G, Gudziol H, Mackay-Sim A. Normative data for the &#x201c;Sniffin&#x2019;&#x2019; Sticks" including tests of odor identification, odor discrimination, and olfactory thresholds: an upgrade based on a group of more than 3,000 subjects&#x201d;. Eur Arch Otorhinolaryngol. 2007;264:237&#x2013;243. doi: 10.1007/S00405-006-0173-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-006-0173-0</ArticleId><ArticleId IdType="pubmed">17021776</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, et al. Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol. 2021;28:3348&#x2013;3359. doi: 10.1111/ene.14803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Damm M, Pikart LK, Reimann H, et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study. Laryngoscope. 2014;124:826&#x2013;831. doi: 10.1002/LARY.24340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/LARY.24340</ArticleId><ArticleId IdType="pubmed">23929687</ArticleId></ArticleIdList></Reference><Reference><Citation>Masala C, Cavazzana A, Sanna F, et al. Correlation between olfactory function, age, sex, and cognitive reserve index in the Italian population. Eur Arch Oto-Rhino-Laryngology. 2022;279:4943. doi: 10.1007/S00405-022-07311-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-022-07311-Z</ArticleId><ArticleId IdType="pmc">PMC8869341</ArticleId><ArticleId IdType="pubmed">35211821</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Merkonidis C, Cuevas M, et al. Intranasal sodium citrate solution improves olfaction in post-viral hyposmia. Rhinology. 2016;54:368&#x2013;373. doi: 10.4193/RHINO16.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/RHINO16.054</ArticleId><ArticleId IdType="pubmed">27316224</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahsler M, Gr&#xfc;n B, Hornik K. Arules&#x2014;a computational environment for mining association rules and frequent item sets. J Stat Softw. 2005 doi: 10.18637/JSS.V014.I15.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/JSS.V014.I15</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert E, Rousseeuw PJ. Lecture notes in computer science (including subseries Lecture notes in artificial intelligence and lecture notes in bioinformatics) Pisa: Springer; 2019. Faster k-medoids clustering: improving the PAM, CLARA, and CLARANS algorithms; pp. 171&#x2013;187.</Citation></Reference><Reference><Citation>Leng M, Wang J, Cheng J, et al. Adaptive semi-supervised clustering algorithm with label propagation. J Softw Eng. 2014;8:14&#x2013;22. doi: 10.3923/jse.2014.14.22.</Citation><ArticleIdList><ArticleId IdType="doi">10.3923/jse.2014.14.22</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal R, Imieli&#x144;ski T, Swami A. Mining association rules between sets of items in large databases. ACM SIGMOD Rec. 1993;22:207&#x2013;216. doi: 10.1145/170036.170072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/170036.170072</ArticleId></ArticleIdList></Reference><Reference><Citation>Teaima AA, Salem OM, Teama MAEM, et al. Patterns and clinical outcomes of olfactory and gustatory disorders in six months: prospective study of 1031 COVID-19 patients. Am J Otolaryngol. 2022 doi: 10.1016/J.AMJOTO.2021.103259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AMJOTO.2021.103259</ArticleId><ArticleId IdType="pmc">PMC8481118</ArticleId><ArticleId IdType="pubmed">34626912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel T, Rissom J, Reden K, et al. Effects of olfactory Training in patients with olfactory loss. Laryngoscope. 2009;119:496&#x2013;499. doi: 10.1002/lary.20101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.20101</ArticleId><ArticleId IdType="pubmed">19235739</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis I, Tsakiropoulou E, Bekiaridou P, et al. Use of olfactory training in post-traumatic and postinfectious olfactory dysfunction. Laryngoscope. 2013 doi: 10.1002/LARY.24390.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/LARY.24390</ArticleId><ArticleId IdType="pubmed">24114690</ArticleId></ArticleIdList></Reference><Reference><Citation>Desiato VM, Levy DA, Byun YJ, et al. The prevalence of olfactory dysfunction in the general population: a systematic review and meta-analysis. Am J Rhinol Allergy. 2021;35:195&#x2013;205. doi: 10.1177/1945892420946254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420946254</ArticleId><ArticleId IdType="pubmed">32746612</ArticleId></ArticleIdList></Reference><Reference><Citation>Oleszkiewicz A, Hummel T. Whose nose does not know? Demographical characterization of people unaware of anosmia. Eur Arch Oto-Rhino-Laryngology. 2019;276:1849. doi: 10.1007/S00405-019-05414-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00405-019-05414-8</ArticleId><ArticleId IdType="pmc">PMC6529373</ArticleId><ArticleId IdType="pubmed">30989334</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>